0001415889-24-020780.txt : 20240805 0001415889-24-020780.hdr.sgml : 20240805 20240805183628 ACCESSION NUMBER: 0001415889-24-020780 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240801 FILED AS OF DATE: 20240805 DATE AS OF CHANGE: 20240805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mirabelli Mary CENTRAL INDEX KEY: 0001937525 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41599 FILM NUMBER: 241176450 MAIL ADDRESS: STREET 1: C/O GENELUX CORPORATION STREET 2: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENELUX Corp CENTRAL INDEX KEY: 0001231457 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: 805-267-9889 MAIL ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER COMPANY: FORMER CONFORMED NAME: GENELUX CORP DATE OF NAME CHANGE: 20030508 4 1 form4-08052024_100824.xml X0508 4 2024-08-01 0001231457 GENELUX Corp GNLX 0001937525 Mirabelli Mary C/O GENELUX CORPORATION 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 true false false false 0 Common Stock 2024-08-01 4 A 0 39541 0 A 52001 D Stock Option Right to Buy) 1.54 2024-08-01 4 A 0 50469 0 A 2034-07-31 Common Stock 50469 50469 D Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. /s/ Thomas Zindrick, J.D., Attorney-in-Fact 2024-08-05